You are elderly with reduced B12 synthesis from food
Many modern treatment options for type 2 diabetes, such as glucagon-like peptide-1 (GLP-1) receptor agonists, take a holistic approach, with substantial reductions in glycated hemoglobin (HbA1c) accompanied by benefits in blood pressure, serum lipid levels and body weight, and low risk of hypoglycemia [1]
Embarking on a Zepbound weight loss regimen often results in noticeable positive changes for patients, such as: Reduced hunger and diminished cravings for high-calorie foods Extended feelings of fullness and satisfaction with meals Enhanced portion control due to a naturally decreasing appetite Gradual, sustainable weight loss without rapid drops that could lead to weight regain Metabolic health enhancements including better blood sugar, blood pressure, and cholesterol levels Patients beginning Zepbound treatment typically observe changes in appetite in the initial weeks
Human COP1 plays a key role in the ubiquitination of a wide range of transcriptional regulators, including p53, c-Jun, and members of the ETS, and C/EBP families 20,25,26,27,28,29
Therapeutic microbiomes and their role in obesity Probiotics Probiotics are live microorganisms that, when administered in sufficient amounts, confer a health benefit on the host. Studies have established a correlation between probiotics and a reduction in body weight for humans and animals (Tables 2 and 3) [209]
Which GLP-1 agonists are available